Please login to the form below

Not currently logged in
Email:
Password:

Epclusa

This page shows the latest Epclusa news and features for those working in and with pharma, biotech and healthcare.

Gilead gets 'gold' in England's hepatitis C eradication drive

Gilead gets 'gold' in England's hepatitis C eradication drive

The programme will include two Gilead hep C drugs at discounted prices: Harvoni and Epclusa, the latter being a 'universal' treatment for all HCV subtypes, including the more hard-to-treat

Latest news

More from news
Approximately 8 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    In other news from Gilead, the company has created a new subsidiary, Asegua Therapeutics, which will launch authorised generic versions of Epclusa and Harvoni, Gilead’s treatments for hepatits C virus

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...

Infographics